-
1 Comment
Solara Active Pharma Sciences Limited is currently in a long term uptrend where the price is trading 22.4% above its 200 day moving average.
From a valuation standpoint, the stock is 39.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Solara Active Pharma Sciences Limited's total revenue rose by 24.2% to $4B since the same quarter in the previous year.
Its net income has increased by 59.1% to $658M since the same quarter in the previous year.
Finally, its free cash flow grew by 18.4% to $1B since the same quarter in the previous year.
Based on the above factors, Solara Active Pharma Sciences Limited gets an overall score of 5/5.
| ISIN | INE624Z01016 |
|---|---|
| Exchange | NSE |
| CurrencyCode | INR |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 22B |
|---|---|
| Target Price | 566 |
| PE Ratio | 3405.0 |
| Beta | 1.11 |
| Dividend Yield | None |
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antifungal, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SOLARA.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
